Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.
Press releases published on June 2, 2025
![[Latest] Global Hybrid Powertrain Market Size/Share Worth USD 483.33 Billion by 2034 at a 15.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, SWOT Analysis)](/images/pressrelease-small.png)
[Latest] Global Hybrid Powertrain Market Size/Share Worth USD 483.33 Billion by 2034 at a 15.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value, SWOT Analysis)
GlobeNewswire
·
June 2, 2025
Austin, TX, USA, June 02, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hybrid Powertrain Market Size, Trends and Insights By Type (Full Hybrid (HEV), Mild Hybrid (MHEV), Plug-In Hybrid (PHEV)), By Vehicle Type …
SAP positioned as the Leader in the 2025 SPARK Matrix: Digital Twin of an Organization Solution by QKS Group
GlobeNewswire
·
June 2, 2025
Middleton, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading Digital Twin of an Organization Solution vendors. SAP, with its comprehensive technology for the Digital Twin …
Green electricity + cloud mining new trend: RichMiner's three secrets to create low-carbon passive income
GlobeNewswire
·
June 2, 2025
New York, NY, June 02, 2025 (GLOBE NEWSWIRE) -- The annual electricity consumption of global cryptocurrency mining has exceeded Argentina's national electricity consumption (data from Cambridge University). Today, when carbon emission reduction has become …
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
GlobeNewswire
·
June 2, 2025
RESEARCH TRIANGLE PARK, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that new data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) will be …
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
June 2, 2025
(OXFORDSHIRE, England …
Marex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading Conference
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (“Marex”), the diversified global financial services platform, announces that it will be participating in a fireside chat at Piper Sandler's Global Exchange …
Nokia and Andorix partner to accelerate Private 5G and Edge solutions in North American real estate market
GlobeNewswire
·
June 2, 2025
Press Release Nokia and Andorix partner to accelerate Private 5G and Edge solutions in North American real estate market Private 5G, Neutral Host Network and Edge Application OT solutions enabled by Nokia Digital Automation Cloud (DAC) to enable efficient …
CW Petroleum Corp (OTCQB: CWPE) Shareholder Update 6/2/2025
GlobeNewswire
·
June 2, 2025
Katy, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors the Company remains on track to …
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
GlobeNewswire
·
June 2, 2025
SAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced new preclinical …
Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
GlobeNewswire
·
June 2, 2025
Phase 1 healthy volunteer data of KT-621, a once-a-day STAT6 degrader, surpass Kymera’s target product profile, significantly derisking program and further validating its oral, biologics-like profile >90% mean STAT6 degradation in blood achieved at all …
Big Names & Fresh Faces Headline Rogers Sports & Media’s Canadian Originals Slate for HGTV and Food Network
GlobeNewswire
·
June 2, 2025
– Rogers Sports …
De grands noms et de nouveaux visages dans les productions originales canadiennes de Rogers Sports & Média sur HGTV et Food Network
GlobeNewswire
·
June 2, 2025
– Rogers Sports …
Coda Octopus Group Sets Fiscal Second Quarter 2025 Earnings Conference Call for Monday, June 16, 2025, at 10 a.m. Eastern Time
GlobeNewswire
·
June 2, 2025
Orlando, FL, June 02, 2025 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for real-time subsea intelligence and new generation augmented …
Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
GlobeNewswire
·
June 2, 2025
Deucrictibant data shows single-dose durability without symptom reoccurrence in the majority of HAE attacks treated First-ever bradykinin B2 receptor mechanism-on-mechanism prophylactic/on-demand data supports potential for deucrictibant portfolio …
BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
GlobeNewswire
·
June 2, 2025
BioNTechs bispezifischer PD-L1xVEGF-Antikörper BNT327 ist ein Immuntherapiekandidat in der fortgeschrittenen klinischen Entwicklung, der das Potenzial hat für verschiedene Tumorarten einen neuen Behandlungsstandard zu setzen, der über die traditionellen …
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
GlobeNewswire
·
June 2, 2025
BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new standard of care in multiple tumor types The co- …
Castellum, Inc. to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd – Thursday, June 5th at 9:00 a.m. EDT
GlobeNewswire
·
June 2, 2025
VIENNA, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) announces that its Chief Executive Officer, Glen Ives, has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” …
Gaza children stand in the palm of memory
MENAFN
·
June 2, 2025
(MENAFN) In the devastated Tel al-Hawa area, located on the western edge of Gaza City, traces of childhood remain scattered beneath the tattered fabric of a makeshift shelter. Fourteen-year-old Kamal Mahdi sits curled up on damp blankets, his slender …
Iran Rejects U.S. Calls, Declares Uranium Enrichment Non-Negotiable
MENAFN
·
June 2, 2025
(MENAFN) Iran’s top nuclear official firmly rejected U.S. calls to halt uranium enrichment, asserting that the process is a non-negotiable cornerstone of the nation’s atomic program. Speaking during an interview broadcast Sunday on a state-run broadcaster, …
Second stage of peace discussions between Russia, Ukraine
MENAFN
·
June 2, 2025
(MENAFN) The second session of peace talks between Russia and Ukraine begun in Istanbul, Türkiye, on Monday, following an escalation in combined drone and missile attacks. Kyiv has increased its use of drones, striking targets within Russian borders …